Renewable Energy Sources (RES) for local development in Cuba is the core topic of an international workshop that begins online tomorrow, organized by the Cuban Society for the Promotion of Renewable Energy Sources and Environmental Respect (CUBASOLAR).

Cuba studied 21,568 samples, resulting in 1,060 positive ones. The country accumulates 3, 385,469 samples taken and 94,571 positive.

The first telephone survey of the National Office of Statistics and Information (ONEI by its Spanish acronym) will begin today in Havana, to inquire into the effects of COVID-19 in the territory.

Cuba's Deputy Minister of Public Health, Carilda Peña García, reiterated the importance of Covid-19 vaccines being a global public good that reaches everyone in a fair, equitable and timely manner.

Specialists with the Havana-based Hematology and Immunology Institute showed local residents a series of educative audiovisuals on hemophilia, marking World Hemophilia Day on Saturday.

Cuba received on Friday the first batch of the 120 thousand syringe and needle kits donated by Cubans living in Panama and friends of the island, in order to support the mass vaccination against Covid-19.

Since March 11, 2020, when COVID-19 was introduced in Cuba, 500 people have died due to this disease, which in recent months has become difficult to control in the third outbreak affecting 190 countries in the world.

Fear does not hinder the willingness of young doctor Eddy Leonardo Perez, another health professional proud to be again in the Red Zone to fight COVID-19, the pandemic that has taken so many human lives.

Lebanon's acting health minister Hamad Hassan informed the Cuban ambassador to that Asian nation, Alexander Pellicer, about his country's interest in the clinical trials of the COVID-19 vaccine candidates developed in Cuba.

The phase II clinical trial of the Soberana Plus vaccine candidate in convalescents will be divided into two stages, explained Dr. Arturo Chang Monteagudo, principal investigator of the study at the Institute of Hematology and Immunology.

The Center for Genetic Engineering and Biotechnology (CIGB) will be able to produce vaccine candidates against original strains of SARS-CoV-2 and mutants starting this month, announced on Thursday Dr. Miladys Limonta Fernandez, coordinator of vaccine candidate development projects of the institution.

A virtual Cuba-Germany business forum held on Wednesday focused on opportunities for cooperation in the area of biotechnology and pharmaceuticals.

Cuba reported on Tuesday 959 new positive cases and eleven deaths as a result of COVID-19.

Mambisa, a vaccine candidate developed by the Cuban Center for Genetic Engineering and Biotechnology (CIGB), is one of the five nasal vaccines in the world now in the stage of clinical trial, CIGB director Marta Ayala Avila told the daily Granma.